UK markets open in 4 hours 19 minutes

NVO Jan 2023 160.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.55000.0000 (0.00%)
As of 02:44PM EDT. Market open.
Full screen
Previous close1.5500
Open1.5200
Bid0.0000
Ask2.5000
Strike160.00
Expiry date2023-01-20
Day's range1.5200 - 1.5500
Contract rangeN/A
Volume30
Open interest84
  • Zacks

    Top Analyst Reports for Novo Nordisk, Suncor Energy, & Nasdaq

    Today's Research Daily features new research reports on 12 major stocks, including Novo Nordisk A/S (NVO), Suncor Energy Inc. (SU) and Nasdaq, Inc. (NDAQ).

  • Motley Fool

    This Big Pharma Stock Just Got an Upgrade. Is It Time to Buy?

    Shares of Eli Lilly (NYSE: LLY) recently ticked higher in response to encouraging words from a Wall Street analyst who follows the pharmaceutical industry. Colin Bristow at UBS, an investment bank, thinks this is the most attractive pharma stock you can buy right now. Is Bristow right about Eli Lilly?

  • Globe Newswire

    Novo Nordisk A/S – Share repurchase programme

    Bagsværd, Denmark, 26 September 2022 – On 3 August 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 24 billion to be executed during a 12-month period beginning 2 February 2022. Under the programme